ESR1 mutation	HER2 Negative Breast Cancer	ESR1 mutation	HER2 Negative Breast Cancer	lasofoxifene Sensitive: C2 – Inclusion Criteria lasofoxifene Sensitive : C2	lasofoxifene Sensitive: C2 – Inclusion Criteria lasofoxifene Sensitive : C2
ER Y537S	Estrogen Receptor Positive Breast Cancer	ER Y537S	Estrogen Receptor Positive Breast Cancer	lasofoxifene Sensitive: D – Preclinical lasofoxifene Sensitive : D	lasofoxifene Sensitive: D – Preclinical lasofoxifene Sensitive : D
ER D538G	Estrogen Receptor Positive Breast Cancer	ER D538G	Estrogen Receptor Positive Breast Cancer	lasofoxifene Sensitive: D – Preclinical lasofoxifene Sensitive : D	lasofoxifene Sensitive: D – Preclinical lasofoxifene Sensitive : D

Fablyn (lasofoxifene)

Associations
(3)